EMA — authorised 25 August 1999
- Marketing authorisation holder: APOTEX EUROPE BV
- Status: approved
EMA authorised Ferriprox on 25 August 1999
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 25 August 1999.
APOTEX EUROPE BV holds the EU marketing authorisation.